Home › All Companies › CDXS › Annual Report

CODEXIS, INC. (CDXS) — Annual Report

AI-Powered SEC Filing Analysis

← All CDXS filings
Latest Annual Report Filed: 2026-03-11

Key Insights

  • Codexis experienced steady revenue growth across its product and research and development segments over the past three years, indicating strong demand for its technology solutions.
  • The company's research and development revenue from key customers like Merck, Nestle, and Novartis has been a significant driver of overall revenue, suggesting successful partnerships and collaborations.
  • Codexis has maintained a healthy balance sheet with increasing cash and cash equivalents, which could support future investments and strategic initiatives.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-11. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for CODEXIS, INC.

Current Report Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.